We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
225 hedge funds and large institutions have $3.5B invested in Acadia Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 84 increasing their positions, 69 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
100.05% more ownership
Funds ownership: 0% → 100.05% (+100%)
22% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 69
6% more call options, than puts
Call options by funds: $103M | Put options by funds: $96.5M
9% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 44
3% less funds holding
Funds holding: 232 → 225 (-7)
6% less capital invested
Capital invested by funds: $3.73B → $3.5B (-$235M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
225
Holders Change
-7
Holders Change %
-3.02%
% of All Funds
5.63%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.13%
New
40
Increased
84
Reduced
69
Closed
44
Calls
$103M
Puts
$96.5M
Net Calls
+$6.1M
Net Calls Change
+$7.45M
Top Buyers
| 1 |
Millennium Management
New York
|
+$46.7M |
| 2 |
Jennison Associates
New York
|
+$36.3M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$30.3M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$29.6M |
| 5 |
SIG
Senator Investment Group
New York
|
+$22.5M |
Top Sellers
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$31.2M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$28.1M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$23.4M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$22.4M |
| 5 |
VanEck Associates
New York
|
-$15.6M |
